Phase i trial of sunitinib malate plus interferon-α for patients with metastatic renal cell carcinoma.
Clinical Genitourinary Cancer.
Times cited: 58
Randomized phase II trial of docetaxel/irinotecan and gemcitabine/ irinotecan with or without celecoxib in the second-line treatment of non-small-cell lung cancer.
Journal of Clinical Oncology.
Times cited: 53